Results 61 to 70 of about 858,069 (214)

Physical activity and activity space in patients with pulmonary fibrosis not prescribed supplemental oxygen

BMC Pulmonary Medicine, 2017
Background Patients with pulmonary fibrosis (PF) have impaired quality of life, and research suggests that dyspnea and physical activity are primary drivers. As PF progresses, some patients notice the disease “shrinks their worlds”. The objective of this
Elisabeth Dowling Root, Bridget Graney, Susan Baird, Tara Churney, Kailtin Fier, Majorie Korn, Mark McCormic, David Sprunger, Tomas Vierzba, Frederick S. Wamboldt, Jeffery J. Swigris   +10 more
doaj   +1 more source

Exosome-Mediated miR-29 Transfer Reduces Muscle Atrophy and Kidney Fibrosis in Mice [PDF]

, 2019
Haidong Wang, Bin Wang, Aiqing Zhang, Faten Hassounah, Yiqi Seow, Matthew J. A. Wood, Fuying Ma, Janet D. Klein, S. Russ Price, Xiaonan H. Wang   +9 more
openalex   +1 more source

ROLE OF NINTEDANIB PLUS LOW-DOSE PIRFENIDONE IN COMPARISON TO SINGLE-DRUG, HIGH-DOSE PIRFENIDONE OR NINTEDANIB IN IDIOPATHIC PULMONARY FIBROSIS: A SINGLE-CENTER, 36-MONTH STUDY [PDF]

, 2023
SHITAL PATIL, GAJANAN GONDHALI, SWATI PATIL   +2 more
openalex   +1 more source

Televisit with TytoHome™ device in medically complex child in long-term mechanical ventilation: a pilot study

Italian Journal of Pediatrics
Background During the pandemic, the pneumology team at Bambino Gesù Children’s Hospital highlighted that telemedicine was a valuable tool for remotely managing the medical needs of children with medical complexity (CMC).
Alessandro Onofri, Nicola Ullmann, Elisabetta Verrillo, Maria Giovanna Paglietti, Martino Pavone, Renato Cutrera   +5 more
doaj   +1 more source

Physicians’ Practices for Diagnosing Liver Fibrosis in Chronic Liver Diseases: A Nationwide, Canadian Survey [PDF]

, 2014
Giada Sebastiani, Peter Ghali, Philip Wong, Marina B. Klein, Marc Deschênes, Robert P. Myers   +5 more
openalex   +1 more source

The complexities of elexacaftor/tezacaftor/ivacaftor therapeutic drug monitoring in a person with cystic fibrosis and Mycobacterium abscessus pulmonary disease

European Clinical Respiratory Journal
Therapeutic drug monitoring (TDM) of elexacaftor/tezacaftor/ivacaftor (ETI) remains challenging due to a lack of clarity around the parameters that govern ETI plasma concentrations, whilst the use of concomitant CYP3A inducers rifabutin and rifampicin is
Claire Y Mou, Daniel J Henderson, Angela G Matson, Karen M Herd, David W Reid, Timothy Riddles, Ellie Johnson, Brett McWhinney, Rebecca Swenson, Andrew Burke, Ieuan E S Evans   +10 more
doaj   +1 more source

Activity of the new cephalosporin CXA-101 (FR264205) against Pseudomonas aeruginosa isolates from chronically infected cystic fibrosis patients [PDF]

, 2009
Laura Zamorano, Carlos Juan, Ana Fernández-Olmos, Yigong Ge, Rafael Cantà n, Antonio Oliver   +5 more
openalex   +1 more source

Identification of BPIFA1/SPLUNC1 as an epithelium-derived smooth muscle relaxing factor

Nature Communications, 2017
Asthma is characterized by abnormal airway hyperresponsiveness. Here the authors identify BPIFA1 as a factor secreted by airway epithelial cells, and show that it regulates contractility of airway smooth muscle cells by binding to and regulating the ...
Tongde Wu, Julianne Huang, Patrick J. Moore, Michael S. Little, William G. Walton, Robert C. Fellner, Neil E. Alexis, Y. Peter Di, Matthew R. Redinbo, Stephen L. Tilley, Robert Tarran   +10 more
doaj   +1 more source

Energy balance and the accuracy of reported energy intake in preadolescent children with cystic fibrosis [PDF]

, 2006
Jillian Trabulsi, Joan I. Schall, Richard F. Ittenbach, Irene E. Olsen, Marc Yudkoff, Yevgeny Daikhin, Babette S. Zemel, Virginia A. Stallings   +7 more
openalex   +1 more source

Is cystic fibrosis an acid mucopolysaccharidosis? [PDF]

, 1976
Rajat Mukherji, P H Moss, C. K. Heffernan   +2 more
openalex   +1 more source